SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial Patients ... Fig 1. CONSORT diagram of ...

CTI has acquired LightWerks of Carson, CA. This expands CTI’s current operations in Los Angeles, Orange County, San Diego, and the San Francisco Bay Area, while bringing Boise, Idaho, and Montana into ...

HHS and FDA are planning to phase out eight synthetic food dyes. During a press conference on Tuesday, Health and Human Services Secretary Robert F. Kennedy Jr. unveiled a plan to start phasing ...

CTI Clinical Trial & Consulting (CTI) has grown from a Cincinnati startup into a global leader in clinical research, playing a pivotal role in advancing life-changing therapies. As the company ...

CTI, one of the largest privately held, U.S.-based AV integration and events providers, has acquired Advanced Systems Integration (ASI) of Burnsville, MN. ASI has built a strong reputation in the ...

The team shares the core values that drive CTI. They’re the right people to expand CTI’s footprint in the region, and I look forward to seeing what they can do with the resources CTI brings,” says ...

Despite their potential, however, the magnetic phase diagram of these materials remains largely unexplored. To uncover more, a team of researchers, led by Professor Ryuji Tamura from the ...

If you buy something via one of our links, we may earn a commission. In a Nutshell The Fischer Transalp 105 CTI is a lightweight, but approachable option for directional skiers looking for a capable ...

myCordenons, a leading Italian manufacturer of luxury specialty papers, announced a new long-term distribution agreement with CTI Paper USA, one of North America’s largest suppliers of premium ...

Further dose escalation in the Phase 2 and OLE trials and the initiation of additional U.S. clinical trials evaluating CTI-1601 are contingent on FDA review of results from the Phase 2 trial’s ...

Sobi has officially acquired CTI, a biopharma company focused on blood related cancers and rare diseases, in a merger valued at approximately $1.7 billion. Swedish Orphan Biovitrum (SOBI), a ...